Skip to main content
. Author manuscript; available in PMC: 2013 Jul 18.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):198–203. doi: 10.1097/WAD.0b013e3181c53b00

FIGURE 2.

FIGURE 2

Transverse fluid-attenuated inversion recovery (FLAIR) and gradient-echo (T2*) magnetic resonance imaging scans showing emergence and resolution of left frontal abnormality on FLAIR 4, 7, and 12 weeks after bapineuzumab administration, with associated dot-like hypointense lesion on T2*, representing a focus of associated microhemorrhage.